Sara Benlloch

6.9k total citations
6 papers, 115 citations indexed

About

Sara Benlloch is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Sara Benlloch has authored 6 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Genetics and 1 paper in Molecular Biology. Recurrent topics in Sara Benlloch's work include Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Genetic Associations and Epidemiology (2 papers). Sara Benlloch is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Genetic Associations and Epidemiology (2 papers). Sara Benlloch collaborates with scholars based in United Kingdom, Sweden and United States. Sara Benlloch's co-authors include Douglas F. Easton, Zsofia Kote‐Jarai, Rosalind A. Eeles, Ali Amin Al Olama, Richard M. Martin, David E. Neal, Jenny Donovan, Freddie C. Hamdy, Mitul Shah and Paul D.P. Pharoah and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Cancer Epidemiology Biomarkers & Prevention.

In The Last Decade

Sara Benlloch

6 papers receiving 115 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Benlloch United Kingdom 5 62 43 29 25 24 6 115
Evelyn Tay Ghana 5 108 1.7× 33 0.8× 31 1.1× 61 2.4× 38 1.6× 5 152
Shingai B.A. Mutambirwa South Africa 6 47 0.8× 22 0.5× 16 0.6× 30 1.2× 16 0.7× 22 92
Holly Ní Raghallaigh United Kingdom 7 78 1.3× 23 0.5× 24 0.8× 24 1.0× 26 1.1× 16 123
C Olier Spain 6 32 0.5× 24 0.6× 72 2.5× 13 0.5× 34 1.4× 21 124
Eveline Niedermayr Australia 2 53 0.9× 37 0.9× 25 0.9× 18 0.7× 30 1.3× 3 87
Goska Leslie United Kingdom 4 39 0.6× 56 1.3× 44 1.5× 23 0.9× 17 0.7× 7 117
S. Peock United Kingdom 2 70 1.1× 46 1.1× 43 1.5× 23 0.9× 43 1.8× 3 111
Katarína Petráková Czechia 7 40 0.6× 37 0.9× 52 1.8× 43 1.7× 39 1.6× 23 113
Charlotte Tyson United Kingdom 5 24 0.4× 32 0.7× 29 1.0× 11 0.4× 23 1.0× 7 85
Daliah Tsoref Israel 6 23 0.4× 41 1.0× 59 2.0× 33 1.3× 66 2.8× 15 166

Countries citing papers authored by Sara Benlloch

Since Specialization
Citations

This map shows the geographic impact of Sara Benlloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Benlloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Benlloch more than expected).

Fields of papers citing papers by Sara Benlloch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Benlloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Benlloch. The network helps show where Sara Benlloch may publish in the future.

Co-authorship network of co-authors of Sara Benlloch

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Benlloch. A scholar is included among the top collaborators of Sara Benlloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Benlloch. Sara Benlloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Eeles, Rosalind A., Ali Amin Al Olama, Sonja Berndt, et al.. (2017). Prostate cancer meta-analysis from more than 145,000 men to identify 65 novel prostate cancer susceptibility loci.. Journal of Clinical Oncology. 2017(1_suppl). 1–1. 6 indexed citations
2.
Eeles, Rosalind A., Ali Amin Al Olama, Sonja I. Berndt, et al.. (2017). Prostate cancer meta-analysis from more than 145,000 men to identify 65 novel prostate cancer susceptibility loci.. Journal of Clinical Oncology. 35(6_suppl). 1–1. 8 indexed citations
3.
Eeles, Rosalind A., Fredrick R. Schumacher, Ali Amin Al Olama, et al.. (2016). Prostate cancer meta-analysis from more than 143,000 men identifies 57 novel prostate cancer susceptibility loci. European Journal of Surgical Oncology. 42(11). S240–S240. 3 indexed citations
4.
Pashayan, Nora, Stephen Duffy, David E. Neal, et al.. (2015). Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis. Genetics in Medicine. 17(10). 789–795. 69 indexed citations
5.
Knipe, Duleeka, David M. Evans, John P. Kemp, et al.. (2014). Genetic Variation in Prostate-Specific Antigen–Detected Prostate Cancer and the Effect of Control Selection on Genetic Association Studies. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1356–1365. 25 indexed citations
6.
Kote‐Jarai, Zsofia, Edward J. Saunders, Daniel Leongamornlert, et al.. (2013). Abstract 2546: Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.. Cancer Research. 73(8_Supplement). 2546–2546. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026